Written by Klarity Editorial Team
Published: May 27, 2026

Medically reviewed content. This article is for informational purposes only and does not constitute medical advice. Always consult a licensed provider before starting, stopping, or changing any medication.
TLDR: Benzodiazepines work fast but carry real risks of dependence and tolerance. SSRIs, SNRIs, buspirone, and hydroxyzine are effective alternatives with different onset times and risk profiles. The right choice depends on your anxiety type, medical history, and treatment goals. A licensed Klarity provider can walk you through the options and help you find what fits.
Benzodiazepines are a class of central nervous system depressants that enhance the effect of gamma-aminobutyric acid (GABA), the brain's primary inhibitory neurotransmitter. By amplifying GABA activity, benzodiazepines produce rapid sedation, muscle relaxation, and anxiolytic (anti-anxiety) effects.
Common benzodiazepines prescribed for anxiety include:
Benzodiazepines for anxiety are among the most prescribed medications in the United States, and their speed of action makes them appealing in acute situations. However, clinical guidelines increasingly recommend them as second-line options or for short-term use only, given their tolerance and dependence profiles (AAFP; PMC/Focus, 2021).
Ready to discuss your anxiety medication options with a licensed provider? See if you may qualify for Xanax treatment online at Klarity — or explore comprehensive online anxiety treatment with Klarity's network of 2,000+ licensed providers.
The anxiety medication comparison landscape has expanded significantly over the past two decades. Benzodiazepines are no longer the only fast or effective option, and several classes have demonstrated strong efficacy with more favorable long-term safety profiles.
SSRIs are the first-line pharmacological treatment for most anxiety disorders according to major clinical guidelines. They work by blocking the reabsorption of serotonin in the brain, increasing the availability of this mood-regulating neurotransmitter.
Common SSRIs for anxiety include:
SSRIs typically take 2 to 6 weeks to produce noticeable effects and 6 to 12 weeks for full benefit. That latency period is the most common patient frustration, but it does not carry dependence risk the way benzodiazepines do (ADAA).
SNRIs work on both serotonin and norepinephrine systems. They are particularly effective for anxiety associated with physical symptoms like tension, pain, and fatigue.
Common SNRIs for anxiety:
Like SSRIs, SNRIs require several weeks to become effective, but they offer strong long-term efficacy without dependence risk.
Buspirone is a non-benzodiazepine anxiolytic that works primarily on serotonin (5-HT1A) receptors and has some dopamine receptor activity. It does not cause sedation or dependence and has no abuse potential, making it a preferred long-term option for generalized anxiety disorder in patients who need to avoid benzodiazepines (GoodRx).
The trade-off: buspirone requires consistent daily dosing (usually twice daily) and takes 2 to 4 weeks to become effective. It does not work on an as-needed basis.
Hydroxyzine (Vistaril, Atarax) is an antihistamine with anxiolytic properties. It works by blocking histamine H1 receptors and has some serotonin antagonist effects. It works within 30 to 60 minutes, making it one of the faster non-benzodiazepine options for acute anxiety.
Hydroxyzine does not cause physical dependence and has no abuse potential. Drowsiness is its primary side effect, which some patients find helpful for anxiety-related sleep disruption.
| Medication Class | Examples | Onset Time | Use Case | Dependence Risk | Controlled Substance? |
|---|---|---|---|---|---|
| Benzodiazepines | Xanax, Ativan, Klonopin, Valium | 15–60 minutes | Acute/panic anxiety, short-term | High | Yes (Schedule IV) |
| SSRIs | Lexapro, Zoloft, Paxil, Prozac | 2–6 weeks | GAD, panic, social anxiety, depression + anxiety | Low (discontinuation syndrome possible) | No |
| SNRIs | Effexor XR, Cymbalta | 2–6 weeks | GAD, panic, pain + anxiety | Low (discontinuation syndrome possible) | No |
| Buspirone | Buspar (generic only) | 2–4 weeks | Long-term GAD management | Very Low | No |
| Hydroxyzine | Vistaril, Atarax | 30–60 minutes | Acute anxiety, situational anxiety | None | No |
Key takeaway from this anxiety medication comparison: faster onset generally correlates with higher dependence risk. Benzodiazepines occupy the fast-acting, high-risk end of the spectrum; SSRIs and SNRIs sit at the slow-acting, low-risk end. Hydroxyzine and buspirone fill the middle ground in different ways.
One of the most practical questions patients ask is how quickly a medication works. Here is a detailed breakdown:
Benzodiazepines (15–60 minutes): Xanax (alprazolam) typically begins working within 15 to 30 minutes of an oral dose, with peak effects at 1 to 2 hours. Klonopin is slower to peak but has a longer duration of action (6 to 12 hours). This rapid onset makes benzodiazepines uniquely useful for panic attacks and acute high-anxiety situations, but it also contributes to their reinforcing properties and dependence potential.
Hydroxyzine (30–60 minutes): Hydroxyzine reaches peak plasma concentrations within about 2 hours. Its anxiolytic effect is noticeable within 30 to 60 minutes, though it does not produce the same intensity of acute relief as benzodiazepines.
SSRIs and SNRIs (2–6 weeks): These medications modify receptor sensitivity and neurotransmitter availability over time. Some patients notice mild mood changes within the first week or two, but clinically meaningful anxiety reduction typically requires 4 to 6 weeks of consistent dosing and may not reach its peak until 8 to 12 weeks.
Buspirone (2–4 weeks): Buspirone's gradual mechanism means patients who expect immediate relief often stop taking it prematurely and mistakenly conclude it does not work. It requires daily consistent use and patience before the full benefit is apparent (Verywell Health).
The Xanax vs. Lexapro comparison comes up frequently because they represent two fundamentally different philosophies of anxiety treatment.
Xanax (alprazolam) is a short-acting benzodiazepine that provides rapid, powerful symptom relief. It is best suited for acute panic episodes and short-term situational anxiety. It is not intended for daily long-term use due to tolerance and physical dependence.
Lexapro (escitalopram) is an SSRI that gradually rebalances serotonin activity over several weeks. It is FDA-approved for generalized anxiety disorder and is suitable for long-term daily maintenance therapy. It does not produce tolerance in the clinical sense and has no abuse potential.
| Factor | Xanax (alprazolam) | Lexapro (escitalopram) |
|---|---|---|
| Drug class | Benzodiazepine | SSRI |
| Onset | 15–30 minutes | 2–6 weeks |
| Ideal use | Acute/panic, short-term | Daily maintenance, long-term |
| Dependence risk | High | Low |
| Controlled substance | Yes (Schedule IV) | No |
| Common side effects | Sedation, dizziness, cognitive blunting | Nausea, insomnia, headache, sexual side effects |
| Treats depression | No | Yes |
For most patients with GAD, panic disorder, or social anxiety disorder, clinical guidelines favor SSRIs like Lexapro as the primary treatment. Benzodiazepines may be appropriate for short-term bridging while waiting for an SSRI to take effect, but they are not recommended as stand-alone long-term therapy (Talkspace; PMC/Focus, 2021).
The Xanax vs. buspirone comparison surfaces often in searches because both are specifically marketed as anti-anxiety medications (unlike SSRIs, which are primarily antidepressants with anxiety indications).
The core difference: Xanax is designed for short-term or as-needed use. Buspirone is designed for daily long-term management of chronic anxiety. They do not fill the same role, and they are not interchangeable.
Who buspirone is right for:
Who may still be considered for benzodiazepines:
The critical point: buspirone does not work on an as-needed basis and produces no acute relief. Patients switching from benzodiazepines to buspirone often feel it is not working because they are habituated to the immediate benzodiazepine response. A tapered transition managed by a licensed provider is the appropriate route (GoodRx).
For more on whether a telehealth provider can prescribe Xanax, see Can a Telehealth Doctor Prescribe Xanax? What to Know on the Klarity blog.
The benzodiazepine risk conversation requires precision. "Dependence," "tolerance," and "addiction" are related but distinct concepts, and conflating them leads to both undertreating and overtreating anxiety.
Tolerance develops when the same dose produces a diminished effect over time. With benzodiazepines, tolerance to the sedative effects develops faster than tolerance to the anxiolytic effects, but both occur with regular use. Some patients find they need progressively higher doses to achieve the same relief.
Physical dependence means the body adapts to the presence of the drug and experiences withdrawal symptoms when it is removed. Benzodiazepine dependence can develop within a few weeks of daily use. Withdrawal symptoms range from rebound anxiety and insomnia to seizures in severe cases — making it essential to taper under medical supervision rather than stopping abruptly (Addiction Center).
Addiction (substance use disorder) involves compulsive use despite harm. Most patients who develop physical dependence are not addicted in the clinical sense, but the distinction matters for treatment planning.
A 2025 joint clinical practice guideline from the American Society of Addiction Medicine specifically addressed benzodiazepine tapering considerations, emphasizing that risks often outweigh benefits for long-term prescribed use in anxiety disorders, and recommended graduated tapering protocols when discontinuation is appropriate (PMC/JGIM, 2025).
Bottom line on risk: benzodiazepines remain clinically appropriate medications for specific, time-limited uses. The risk profile does not mean they should never be prescribed — it means they require careful, informed prescribing and regular reassessment by a qualified provider.
Benzodiazepines are appropriate when:
SSRIs/SNRIs are appropriate when:
Buspirone is appropriate when:
Hydroxyzine is appropriate when:
No anxiety medication comparison table can replace an individualized clinical assessment. Klarity's network of 2,000+ licensed providers approaches anxiety treatment by considering multiple factors before recommending any medication.
A typical Klarity evaluation looks at:
Anxiety type and severity — GAD, panic disorder, social anxiety disorder, and situational anxiety have different first-line medication recommendations. A provider distinguishes between them before selecting a medication class.
Duration and acuity — Acute anxiety that has appeared suddenly in the context of a life event calls for a different approach than chronic, years-long generalized anxiety. The former may warrant short-term benzodiazepine use; the latter almost always favors SSRIs or SNRIs as the backbone of treatment.
Comorbidities — Depression co-occurring with anxiety strongly favors an SSRI or SNRI, which can address both conditions simultaneously. Benzodiazepines do not treat depression.
Substance use history — Patients with a personal or family history of substance use disorder are generally better served by non-controlled options like buspirone, SSRIs, SNRIs, or hydroxyzine.
Current medications and interactions — Benzodiazepines carry significant interaction risks with opioids, alcohol, and many other CNS agents. A complete medication review is standard before any prescription.
Patient goals and lifestyle — Some patients need to remain cognitively sharp for work or caregiving; benzodiazepine sedation is not compatible with that requirement. Others need rapid relief for specific, predictable high-anxiety situations.
Prior medication history — What has the patient tried before? What worked, what did not, and why? Prior response to a medication class is often the strongest predictor of future response.
The goal is not to find a "best" anxiety medication in the abstract. It is to find the right medication for this patient's specific clinical picture. That distinction drives every prescribing decision within the Klarity network.
Medication costs vary widely depending on the drug, your insurance plan, and your state.
Many insurance plans may cover online anxiety treatment through telehealth providers like Klarity. Coverage varies by plan, state, and provider network. Patients should verify their benefits before booking. If your insurance may cover mental health services, check whether your plan may cover online anxiety care at Klarity.
Insurance coverage disclaimer: Coverage for mental health treatment, including online appointments and prescription management, varies by insurance plan. Klarity does not guarantee reimbursement. Patients should contact their insurance provider directly to verify mental health benefits, telehealth coverage, and medication copays before their appointment.
"Better" depends entirely on the clinical situation. Benzodiazepines work faster and are more effective for acute panic attacks. SSRIs are more appropriate for ongoing daily management of chronic anxiety disorders. Most clinical guidelines position SSRIs and SNRIs as first-line treatments for anxiety disorders and reserve benzodiazepines for short-term or adjunctive use.
Some providers do prescribe both during the early weeks of SSRI treatment, using a benzodiazepine as a bridge while the SSRI reaches therapeutic effect. This is typically a short-term strategy. The combination carries interaction risks and requires close provider supervision.
For generalized anxiety disorder managed long-term, buspirone shows comparable efficacy to benzodiazepines in clinical studies, with a significantly better safety profile. For acute panic attacks, buspirone is not effective — it does not provide rapid symptom relief.
SSRIs, SNRIs, and buspirone are generally considered the safest options for long-term anxiety management. They do not cause physical dependence in the way benzodiazepines do, and they do not carry the same cognitive and motor impairment risks.
Yes, in most states a licensed telehealth provider can prescribe anxiety medications including SSRIs, SNRIs, buspirone, and hydroxyzine. Controlled substances like benzodiazepines have additional regulatory requirements that vary by state and provider. Klarity's providers are familiar with these requirements and will discuss appropriate options during your appointment.
The only reliable answer comes from a clinical evaluation with a licensed provider who can assess your specific symptoms, history, and goals. Comparison articles provide useful background knowledge, but they cannot replace that individualized assessment.
The benzodiazepine vs. anxiety medication question does not have a single universal answer. Benzodiazepines work fast and are clinically appropriate in specific contexts. SSRIs and SNRIs are the evidence-backed first-line choice for most chronic anxiety disorders. Buspirone offers long-term management without dependence risk. Hydroxyzine provides rapid relief without controlled-substance status.
The decision belongs in a conversation with a licensed provider who can weigh your full clinical picture.
Klarity connects you with 2,000+ licensed providers for online anxiety treatment, with appointments often available within days. Verify your benefits and see if you may qualify for online anxiety care, or learn more about Xanax prescription options online.
This article is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Medication decisions should be made in consultation with a licensed healthcare provider. If you are experiencing a mental health crisis, contact the 988 Suicide and Crisis Lifeline by calling or texting 988.
Find the right provider for your needs — select your state to find expert care near you.